The Enroll-HD platform will soon be recruiting participants. Most of these studies are recruiting people who are already participating in Enroll-HD. Please find a site near you and contact the study coordinator listed for that site. buff.ly/MmDcMrX

UniQure secured a Type A FDA meeting, a high-priority discussion for urgent issues. Within 30 days, both parties will discuss the type of data package that might support the advancement of AMT-130 in the US. buff.ly/7Db7pEz

Research suggests that vaccines may reduce the risk of dementia by 20%. Infections cause inflammation and toxic byproducts that mitochondria normally clear. In HD, where mitochondria are impaired, vaccination is especially crucial. buff.ly/jVygBEd

UniQure secured a Type A FDA meeting, a high-priority discussion for urgent issues. Within 30 days, both sides will discuss what kind of data package might support the advancement of AMT-130 in the US. buff.ly/7Db7pEz

Join us for the 8th Annual San Jose Team Hope 5k Walk and 5k Timed Run scheduled for Saturday, May 16th, 2026, at Campbell Park. NEW: Registration is FREE for all Team Hope events this year! Fundraise $100 and get a Team Hope Walk t-shirt. Register here: buff.ly/viqQviX

Keeping up with HD research just got easier with the Introduction of the HDBuzz Trial Tracker. The HDBuzz Trial Tracker will put future updates for HD trials on a clear timeline, with deeper explanations in their articles when you want them. buff.ly/C3Vt7wI

Most people with HD report sleep problems, & new research suggests sleep quality is linked to many aspects of living with the disease. Wearables tracked people with HD for a year & revealed better sleep & strength training might help. buff.ly/vEY5URD

The San Jose Team Hope Walk & 5K Timed Run is our annual fundraising event, raising critical funds to support programs and services for local families affected by HD. Help us reach our goal of raising $26,500. buff.ly/viqQviX

The Huntington’s disease community's unprecedented mobilization helped secure a high-priority FDA meeting to discuss the path forward for AMT-130. buff.ly/LiWttVl

Bring Hope to Huntington's Disease Families: Urge the FDA to Uphold Accelerated Approval. Please Sign The Petition Here: buff.ly/CLD6Aih

The Huntington’s disease community’s unprecedented mobilization helped secure a high-priority FDA meeting to discuss the path forward for AMT-130. Check here for details: buff.ly/LiWttVl

Skyhawk Therapeutics shared results for SKY-0515, a drug designed to lower huntingtin. The drug appeared generally safe, with 60% reduction of huntingtin in blood at the highest dose tested. This data is an encouraging step as larger trials continue. buff.ly/PlwJVeU